With the emerging developments of the coronavirus, our team worked with clients and Vancery members to draw clarity from top leaders in the fields of pharmaceuticals, virology, and epidemiology on this emerging topic.
Our goal was to ask the people who will actually be involved in creating and manufacturing new medicines for the disease in the coming months just what they believed would unfold.
With their help and an opinion survey ran on the Vancery platform, we were able to draw some conclusions that serve as a best guess for potential developments of the virus. We take the opportunity to share their thoughts with you, to aid in your own personal and business decision-making.
1) At this point, the virus’ spread is likely unavoidable in the US…
 |
2) However, the infection rate can be expected to be approximately 25%, which is far lower than is widely reported…
 |
3) Furthermore, while many respondents believed that the ultimate mortality rate be in the 1-2% range (as widely reported), a plurality of our respondents expect the mortality rate in the US to be very low, actually less than 0.025%…
 |
4) It is likely that the virus will slow in warmer weather and it is clear that that temperatures will need to rise consistently above 60 degrees Fahrenheit for weather to become a strong mitigant to the virus’ spread…
 |
5) A plurality of respondents believe that it will take at least 12 months for an effective vaccine to be widely deployed…
 |
6) It is most likely that a vaccine will be developed here in the US…
 |
7) The company best positioned to create an effective therapeutic to the disease is Gilead Sciences…
 |
Vancery was founded to empower people to connect with their peers to share knowledge and to collaborate. We believe there is extraordinary value in both the individual and collective ideas of our members. It is our hope that this post has provided some very educated opinions to a highly fluid and important topic.
If you’d like to participate in surveys like this in the future, or engage directly with our clients on your area of expertise, join our community here.